1.33% 1.0447

Intra Cellular Therapies Inc (ITCI)

Intra Cellular Therapies Inc Borsa (ITCI) Ultime notizie

Intra Cellular Therapies Inc (ITCI)

Intra Cellular Therapies Inc Borsa (ITCI) Ultime notizie

Intra-Cellular Therapies (NASDAQ:ITCI) Receives Overweight Rating from Cantor Fitzgerald - Defense World

Intra-Cellular Therapies (NASDAQ:ITCI) Receives "Overweight" Rating from Cantor Fitzgerald - MarketBeat

Los Angeles Capital Management LLC Sells 6,045 Shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - Defense World

First Turn Management LLC Purchases 140,636 Shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - MarketBeat

Intra-Cellular Therapies (NASDAQ:ITCI) delivers shareholders fantastic 54% CAGR over 5 years, surging 3.9% in the last week alone - Yahoo Finance

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Shares Bought by Nicholas Investment Partners LP - MarketBeat

Pier Capital LLC Buys 10,050 Shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - MarketBeat

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat

Investing in Intra-Cellular Therapies Inc (ITCI): What You Must Know - Knox Daily

S&P 500 Futures Climb in Premarket Trading; Summit Therapeutics, Palantir Technologies Lead - Barron's

Piper Sandler upgrades Intra-Cellular to “Overweight” - TradingPedia

Emerald Advisers LLC Sells 9,020 Shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - MarketBeat

Intra-Cellular Therapies (NASDAQ:ITCI) Shares Gap Up to $72.42 - Defense World

Intra-Cellular Therapies (NASDAQ:ITCI) Rating Increased to Overweight at Piper Sandler - MarketBeat

Expert Ratings For Intra-Cellular Therapies - Benzinga

Why Is Intra-Cellular (ITCI) Down 2.7% Since Last Earnings Report? - Yahoo Finance

Intra-Cellular Therapies (NASDAQ:ITCI) Shares Gap Up to $72.42 - MarketBeat

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Shares Sold by Bank of New York Mellon Corp - MarketBeat

Intra-Cellular Therapies, Inc. (ITCI): Among the Best Mid-Cap Healthcare Stocks To Buy Now - Yahoo Finance

Intra-Cellular Therapies, Inc. (ITCI): Among the Best Mid-Cap Healthcare Stocks To Buy Now - MSN

Intra-Cellular Therapies, Inc. (ITCI): Among the Best Mid-Cap Healthcare Stocks To Buy Now - Insider Monkey

How To Trade (ITCI) - Stock Traders Daily

Peaking Back In On Intra-Cellular Therapies (NASDAQ:ITCI) - Seeking Alpha

Maryland State Retirement & Pension System Takes Position in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - MarketBeat

10 Best Mid-Cap Healthcare Stocks To Buy Now - Insider Monkey

Allspring Global Investments Holdings LLC Increases Stake in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - MarketBeat

Privium Fund Management B.V. Has $8.09 Million Stake in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - MarketBeat

When Will Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Breakeven? - Simply Wall St

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) CEO Sharon Mates Sells 34,396 Shares - MarketBeat

Intra-Cellular Therapies CEO sells over $5 million in company stock - Investing.com

Intra-Cellular Therapies CEO sells over $7m in stock By Investing.com - Investing.com Australia

Raymond James Trust N.A. Sells 194 Shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - Defense World

Intra-Cellular Therapies CEO sells over $7m in stock - Investing.com

Intra-Cellular Therapies to Present at Three Upcoming Investor Conferences - Markets Insider

Intra-Cellular Therapies to Present at Three Upcoming Investor Conferences - GlobeNewswire

Intra-Cellular Therapies to Present at Three Upcoming Investor Conferences - Yahoo Finance

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) CEO Sells $2,980,946.54 in Stock - MarketBeat

Legato Capital Management LLC Purchases 9,923 Shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - MarketBeat

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Shares Bought by Calamos Advisors LLC - Defense World

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Shares Acquired by Calamos Advisors LLC - MarketBeat

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Holdings Decreased by Nisa Investment Advisors LLC - Defense World

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) CEO Sharon Mates Sells 28,680 Shares of Stock - Defense World

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) CEO Sharon Mates Sells 53,013 Shares of Stock - Defense World

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) CEO Sharon Mates Sells 28,680 Shares - MarketBeat

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Shares Sold by Envestnet Portfolio Solutions Inc. - Defense World

Intra-Cellular Therapies (NASDAQ:ITCI) Given New $81.00 Price Target at JPMorgan Chase & Co. - Defense World

Intra-Cellular Therapies (NASDAQ:ITCI) PT Raised to $81.00 at JPMorgan Chase & Co. - MarketBeat

Intra-Cellular Therapies executive sells over $1.4m in stock By Investing.com - Investing.com Australia

Weekly Research Analysts’ Ratings Changes for Intra-Cellular Therapies (ITCI) - Defense World

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) EVP Mark Neumann Sells 18,714 Shares - Defense World

Intra-Cellular Therapies executive sells over $1.4m in stock - Investing.com India

Intra-Cellular Therapies executive sells over $1.4m in stock By Investing.com - Investing.com Canada

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) EVP Sells $1,405,047.12 in Stock - MarketBeat

Intra-Cellular Therapies executive sells over $1.4m in stock By Investing.com - Investing.com UK

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Shares Purchased by Cwm LLC - Defense World

Here's Why We're Not At All Concerned With Intra-Cellular Therapies' (NASDAQ:ITCI) Cash Burn Situation - Yahoo Finance

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Sees Significant Decrease in Short Interest - Defense World

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Sees Significant Decline in Short Interest - MarketBeat

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World

Assenagon Asset Management S.A. Reduces Stake in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - MarketBeat

Simile a ITCI